PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer

BackgroundThere is increasing evidence that group 2 innate lymphoid cells (ILC2s) play an essential role in allergy and parasitic infection. However, the role of ILC2s in human lung cancer remains unclear.MethodsILC2s from peripheral blood mononuclear cells (PBMCs) obtained from healthy donors (HDs)...

Full description

Bibliographic Details
Main Authors: Chunyi Shen, Chaojun Liu, Zhen Zhang, Yu Ping, Jingwen Shao, Yonggui Tian, Weina Yu, Guohui Qin, Shasha Liu, Liping Wang, Yi Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.680055/full
id doaj-d736f4099110474eb74b7d58943360db
record_format Article
spelling doaj-d736f4099110474eb74b7d58943360db2021-06-14T15:28:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-06-011210.3389/fimmu.2021.680055680055PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung CancerChunyi Shen0Chaojun Liu1Zhen Zhang2Zhen Zhang3Yu Ping4Jingwen Shao5Yonggui Tian6Weina Yu7Guohui Qin8Guohui Qin9Shasha Liu10Liping Wang11Yi Zhang12Yi Zhang13Yi Zhang14Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaState Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaState Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaState Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, ChinaBackgroundThere is increasing evidence that group 2 innate lymphoid cells (ILC2s) play an essential role in allergy and parasitic infection. However, the role of ILC2s in human lung cancer remains unclear.MethodsILC2s from peripheral blood mononuclear cells (PBMCs) obtained from healthy donors (HDs) and non-small cell lung cancer (NSCLC) patients, and NSCLC tumor tissues were analyzed via multicolor flow cytometry. ILC2s or CD14+ cells were sorted by fluorescence-activated cell sorting. qPCR and flow cytometry were performed to assess the gene and protein expression of the indicated molecules. M1-like and M2-like macrophages were induced from CD14+ monocytes in vitro.ResultsILC2s were significantly more enriched in PBMCs and tumor tissues from NSCLC patients than in HDs. After screening for the main immune checkpoint molecules, we found that PD-1 was upregulated in ILC2s in NSCLC patients. Functionally, PD-1high ILC2s from tumor tissues expressed higher levels of IL-4 and IL-13 regarding both mRNA and protein levels than PD-1low ILC2s. Furthermore, PD-1high ILC2s robustly boosted M2-like macrophage polarization in vitro, by secreting IL-4 and IL-13, while neutralization of IL-4 and IL-13 by antibodies abrogated M2-like macrophage polarization.ConclusionILC2s are enriched in NSCLC patients and upregulate PD-1 expression. Upregulation of PD-1 facilitates the immunosuppressive function of ILC2s. PD-1high ILC2s enhance M2-like macrophage polarization by secreting IL-4 and IL-13. PD-1 acts as a positive regulator of the immunosuppressive function of ILC2s in human NSCLC.https://www.frontiersin.org/articles/10.3389/fimmu.2021.680055/fullinnate immune responsenon-small cell lung cancerprogrammed cell death protein 1group 2 innate lymphoid cellstype 2 macrophage
collection DOAJ
language English
format Article
sources DOAJ
author Chunyi Shen
Chaojun Liu
Zhen Zhang
Zhen Zhang
Yu Ping
Jingwen Shao
Yonggui Tian
Weina Yu
Guohui Qin
Guohui Qin
Shasha Liu
Liping Wang
Yi Zhang
Yi Zhang
Yi Zhang
spellingShingle Chunyi Shen
Chaojun Liu
Zhen Zhang
Zhen Zhang
Yu Ping
Jingwen Shao
Yonggui Tian
Weina Yu
Guohui Qin
Guohui Qin
Shasha Liu
Liping Wang
Yi Zhang
Yi Zhang
Yi Zhang
PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer
Frontiers in Immunology
innate immune response
non-small cell lung cancer
programmed cell death protein 1
group 2 innate lymphoid cells
type 2 macrophage
author_facet Chunyi Shen
Chaojun Liu
Zhen Zhang
Zhen Zhang
Yu Ping
Jingwen Shao
Yonggui Tian
Weina Yu
Guohui Qin
Guohui Qin
Shasha Liu
Liping Wang
Yi Zhang
Yi Zhang
Yi Zhang
author_sort Chunyi Shen
title PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer
title_short PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer
title_full PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer
title_fullStr PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer
title_full_unstemmed PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer
title_sort pd-1 affects the immunosuppressive function of group 2 innate lymphoid cells in human non-small cell lung cancer
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-06-01
description BackgroundThere is increasing evidence that group 2 innate lymphoid cells (ILC2s) play an essential role in allergy and parasitic infection. However, the role of ILC2s in human lung cancer remains unclear.MethodsILC2s from peripheral blood mononuclear cells (PBMCs) obtained from healthy donors (HDs) and non-small cell lung cancer (NSCLC) patients, and NSCLC tumor tissues were analyzed via multicolor flow cytometry. ILC2s or CD14+ cells were sorted by fluorescence-activated cell sorting. qPCR and flow cytometry were performed to assess the gene and protein expression of the indicated molecules. M1-like and M2-like macrophages were induced from CD14+ monocytes in vitro.ResultsILC2s were significantly more enriched in PBMCs and tumor tissues from NSCLC patients than in HDs. After screening for the main immune checkpoint molecules, we found that PD-1 was upregulated in ILC2s in NSCLC patients. Functionally, PD-1high ILC2s from tumor tissues expressed higher levels of IL-4 and IL-13 regarding both mRNA and protein levels than PD-1low ILC2s. Furthermore, PD-1high ILC2s robustly boosted M2-like macrophage polarization in vitro, by secreting IL-4 and IL-13, while neutralization of IL-4 and IL-13 by antibodies abrogated M2-like macrophage polarization.ConclusionILC2s are enriched in NSCLC patients and upregulate PD-1 expression. Upregulation of PD-1 facilitates the immunosuppressive function of ILC2s. PD-1high ILC2s enhance M2-like macrophage polarization by secreting IL-4 and IL-13. PD-1 acts as a positive regulator of the immunosuppressive function of ILC2s in human NSCLC.
topic innate immune response
non-small cell lung cancer
programmed cell death protein 1
group 2 innate lymphoid cells
type 2 macrophage
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.680055/full
work_keys_str_mv AT chunyishen pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT chaojunliu pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT zhenzhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT zhenzhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT yuping pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT jingwenshao pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT yongguitian pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT weinayu pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT guohuiqin pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT guohuiqin pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT shashaliu pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT lipingwang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT yizhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT yizhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
AT yizhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer
_version_ 1721378195324796928